INDICATION: Mesalamine delayed-release tablets are indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for the maintenance of remission of ulcerative colitis
WARNING: Drug, To be sold by retail on the prescription of Registered Medical Practitioner only